Tech Company Financing Transactions
Compound Therapeutics Funding Round
Atlas Venture, Flagship Pioneering and Polaris Partners participated in a $15.5 million Series A venture round for Compound Therapeutics. The financing round was announced on 1/18/2005.
Transaction Overview
Company Name
Announced On
1/18/2005
Transaction Type
Venture Equity
Amount
$15,500,000
Round
Series A
Investors
Proceeds Purpose
These funds will be used to advance Compound's lead oncology product candidate into the clinic and to build the company's pipeline by moving additional programs into preclinical development.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
100 Beaver Street
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Website
Email Address
Overview
Compound Therapeutics is a product discovery and development company creating the next generation of biotherapeutics using three proprietary technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
John Edwards
Vice President
Sharon Cload
VP - Human Resources
Erin Lanciani
VP - Manufacturing
Alex Chu
VP - Product Management
Kelledy Manson
VP - R & D
Eric Furfine
Browse more venture capital transactions:
Prev: 1/18/2005: Unitrends Software venture capital transaction
Next: 1/18/2005: GeneOhm Sciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs